Anagram Therapeutics News and Activities

Acquisition, funding and merger involving Anagram Therapeutics.

• Anagram Therapeutics has just announced a $250 Million fundraising (posted on May 8 2026).

View the org chart displaying its 19 main executives

Most searched biographies at Anagram Therapeutics

• Robert Gallotto, Chief Executive Officer
• Aditya Karhade, Director
• Drucy Borowitz, Director

Popular executive movements at Anagram Therapeutics

• Hugh Wight, who was Chief Corporate Development Officer, is promoted to Chief Operating Officer  (posted on May 8 2026).

Create your alert
to follow the executive moves at Anagram Therapeutics.

Anagram Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Anagram Therapeutics

Social media about Anagram Therapeutics

• Anagram Therapeutics on Wikipedia, Google News & Yahoo Finance
• Anagram Therapeutics on LinkedIn, X (Twitter) & YouTube